Progyny, Inc.
PGNY
$26.69
-$0.02-0.08%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 313.35M | 332.87M | 324.04M | 298.43M | 286.63M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 313.35M | 332.87M | 324.04M | 298.43M | 286.63M |
| Cost of Revenue | 240.51M | 253.90M | 248.24M | 235.00M | 227.38M |
| Gross Profit | 72.84M | 78.97M | 75.80M | 63.43M | 59.24M |
| SG&A Expenses | 51.31M | 54.62M | 51.63M | 47.65M | 46.79M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 291.82M | 308.52M | 299.87M | 282.64M | 274.17M |
| Operating Income | 21.53M | 24.36M | 24.17M | 15.79M | 12.46M |
| Income Before Tax | 23.96M | 27.08M | 26.54M | 17.66M | 17.96M |
| Income Tax Expenses | 10.10M | 9.97M | 11.48M | 7.13M | 7.54M |
| Earnings from Continuing Operations | 13.86M | 17.11M | 15.06M | 10.53M | 10.42M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 13.86M | 17.11M | 15.06M | 10.53M | 10.42M |
| EBIT | 21.53M | 24.36M | 24.17M | 15.79M | 12.46M |
| EBITDA | 22.80M | 25.56M | 25.28M | 16.66M | 13.30M |
| EPS Basic | 0.16 | 0.20 | 0.18 | 0.12 | 0.12 |
| Normalized Basic EPS | 0.17 | 0.20 | 0.19 | 0.13 | 0.10 |
| EPS Diluted | 0.15 | 0.19 | 0.17 | 0.12 | 0.11 |
| Normalized Diluted EPS | 0.17 | 0.19 | 0.19 | 0.12 | 0.10 |
| Average Basic Shares Outstanding | 86.02M | 85.77M | 85.50M | 85.81M | 90.07M |
| Average Diluted Shares Outstanding | 90.23M | 89.64M | 89.31M | 88.91M | 93.82M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |